JoVE Logo

Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Results
  • Discussion
  • Disclosures
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

Channelrhodopsin-assisted circuit mapping (CRACM) is a precision technique for functional mapping of long-range neuronal projections between anatomically and/or genetically identified groups of neurons. Here, we describe how to utilize CRACM to map auditory brainstem connections, including the use of a red-shifted opsin, ChrimsonR.

Abstract

When investigating neural circuits, a standard limitation of the in vitro patch clamp approach is that axons from multiple sources are often intermixed, making it difficult to isolate inputs from individual sources with electrical stimulation. However, by using channelrhodopsin assisted circuit mapping (CRACM), this limitation can now be overcome. Here, we report a method to use CRACM to map ascending inputs from lower auditory brainstem nuclei and commissural inputs to an identified class of neurons in the inferior colliculus (IC), the midbrain nucleus of the auditory system. In the IC, local, commissural, ascending, and descending axons are heavily intertwined and therefore indistinguishable with electrical stimulation. By injecting a viral construct to drive expression of a channelrhodopsin in a presynaptic nucleus, followed by patch clamp recording to characterize the presence and physiology of channelrhodopsin-expressing synaptic inputs, projections from a specific source to a specific population of IC neurons can be mapped with cell type-specific accuracy. We show that this approach works with both Chronos, a blue light-activated channelrhodopsin, and ChrimsonR, a red-shifted channelrhodopsin. In contrast to previous reports from the forebrain, we find that ChrimsonR is robustly trafficked down the axons of dorsal cochlear nucleus principal neurons, indicating that ChrimsonR may be a useful tool for CRACM experiments in the brainstem. The protocol presented here includes detailed descriptions of the intracranial virus injection surgery, including stereotaxic coordinates for targeting injections to the dorsal cochlear nucleus and IC of mice, and how to combine whole cell patch clamp recording with channelrhodopsin activation to investigate long-range projections to IC neurons. Although this protocol is tailored to characterizing auditory inputs to the IC, it can be easily adapted to investigate other long-range projections in the auditory brainstem and beyond.

Introduction

Synaptic connections are critical to neural circuit function, but the precise topology and physiology of synapses within neural circuits are often difficult to probe experimentally. This is because electrical stimulation, the traditional tool of cellular electrophysiology, indiscriminately activates axons near the stimulation site, and in most brain regions, axons from different sources (local, ascending, and/or descending) intertwine. However, by using channelrhodopsin assisted circuit mapping (CRACM)1,2, this limitation can now be overcome3. Channelrhodopsin (ChR2) is a light activated, cation-selective ion channel originally found in the green alga Chlamydomonas reinhardtii. ChR2 can be activated by blue light of a wavelength around 450-490 nm, depolarizing the cell through cation influx. ChR2 was first described and expressed in Xenopus oocytes by Nagel and colleagues4. Shortly after that, Boyden and colleagues5 expressed ChR2 in mammalian neurons and showed that they could use light pulses to reliably control spiking on a millisecond timescale, inducing action potentials ~10 ms after activation of ChR2 with blue light. Optogenetic channels with even faster kinetics have been found recently (e.g., Chronos6).

The basic approach to a CRACM experiment is to transfect a population of putative presynaptic neurons with a recombinant adeno-associated virus (rAAV) that carries the genetic information for a channelrhodopsin. Transfection of neurons with rAAV leads to the expression of the encoded channelrhodopsin. Typically, the channelrhodopsin is tagged with a fluorescent protein like GFP (Green Fluorescent Protein) or tdTomato (a red fluorescent protein), so that transfection of neurons in the target region can easily be confirmed with fluorescence imaging. Because rAAVs are non-pathogenic, have a low inflammatory potential and long-lasting gene expression7,8, they have become a standard technique to deliver channelrhodopsins to neurons. If, after transfection of a putative presynaptic population of neurons, activation of a channelrhodopsin through light flashes elicits postsynaptic potentials or currents in the target neurons, this is evidence of an axonal connection from the transfected nucleus to the recorded cell. Because severed axons in brain slice experiments can be driven to release neurotransmitter through channelrhodopsin activation, nuclei that lie outside of the acute slice but send axons into the postsynaptic brain region can be identified with CRACM. The power of this technique is that the connectivity and physiology of identified long range synaptic inputs can be directly investigated.

In addition to channelrhodopsins that are excitable by blue light, investigators have recently identified several red-shifted channelrhodopsins9,10, including Chrimson and its faster analog ChrimsonR, both of which are excited with red light of ~660 nm6. Red-shifted opsins are of interest because red light penetrates tissue better than blue light, and red light may have a lower cytotoxicity than blue light10,11,12. Red-shifted channelrhodopsins also open up the possibility of dual color CRACM experiments, where the convergence of axons from different nuclei on the same neuron can be tested in one experiment6,13,14. However, current red-shifted opsins often exhibit unwanted cross-activation with blue light15,16,17, making two color experiments difficult. In addition, some reports have indicated that ChrimsonR undergoes limited axonal trafficking, which can make it challenging to use ChrimsonR for CRACM experiments16,17.

Nearly all ascending projections from the lower auditory brainstem nuclei converge in the inferior colliculus (IC), the midbrain hub of the central auditory pathway. This includes projections from the cochlear nucleus (CN)18,19, most of the superior olivary complex (SOC)20, and the dorsal (DNLL) and ventral (VNLL) nuclei of the lateral lemniscus21. Additionally, a large descending projection from the auditory cortex terminates in the IC18,19,20,21,22, and IC neurons themselves synapse broadly within the local and contralateral lobes of the IC23. The intermingling of axons from many sources has made it difficult to probe IC circuits using electrical stimulation24. As a result, even though neurons in the IC perform computations important for sound localization and the identification of speech and other communication sounds25,26, the organization of neural circuits in the IC is largely unknown. We recently identified VIP neurons as the first molecularly identifiable neuron class in the IC27. VIP neurons are glutamatergic stellate neurons that project to several long-range targets, including the auditory thalamus and superior colliculus. We are now able to determine the sources and function of local and long-range inputs to VIP neurons and to determine how these circuit connections contribute to sound processing.

The protocol presented here is tailored to investigating synaptic inputs to VIP neurons in the IC of mice, specifically from the contralateral IC and the DCN (Figure 1). The protocol can be easily adapted to different sources of input, a different neuron type or a different brain region altogether. We also show that ChrimsonR is an effective red-shifted channelrhodopsin for long range circuit mapping in the auditory brainstem. However, we demonstrate that ChrimsonR is strongly activated by blue light, even at low intensities, and thus, to combine ChrimsonR with Chronos in two-color CRACM experiments, careful controls must be used to prevent cross-activation of ChrimsonR.

Protocol

Obtain approval from the local Institutional Animal Care and Use Committee (IACUC) and adhere to NIH guidelines for the care and use of laboratory animals. All procedures in this protocol were approved by the University of Michigan IACUC and were in accordance with NIH guidelines for the care and use of laboratory animals.

1. Surgery Preparations

  1. Perform surgeries in aseptic conditions. Autoclave/sterilize all surgery tools and materials before surgery. Wear surgery gown and mask for the surgery.
  2. Sanitize the surgery area (spray and wipe down with 70% ethanol), and place sterile towel drapes to cover the surgery area.
  3. Prepare the recovery cage. Remove cage bedding to limit risk of asphyxiation. Put a heating pad under cage. Provide a food and water source.
  4. Pull a glass capillary for the nanoinjector on a pipette puller. The intense heat of the heating filament during the pulling process will sterilize the glass capillary. Cut or break off the tip to obtain an opening approximately 5 µm in diameter.
  5. Bevel the capillary tip to an approximately 30° angle to improve tissue penetration and reduce clogging. Backfill the capillary with mineral oil and insert into a nanoliter injector.
  6. Obtain an aliquot of the desired channelrhodopsin-encoding rAAV and dilute to the desired titer using sterile PBS.
    NOTE: We have found that serotype 1 rAAVs work well for transfection of auditory brainstem nuclei. Specifically, rAAV1.Syn.Chronos-GFP.WPRE.bGH (blue light-activated channelrhodopsin) and rAAV1.Syn.ChrimsonR-tdTomato.WPRE.bGH (red-shifted channelrhodopsin), which are available from publically accessible repositories and vector cores, consistently yield the high expression levels and good long-range axonal trafficking of channelrhodopsins needed for CRACM experiments.
  7. Follow injector instructions to front fill capillary with 1-3 µL of rAAV in sterile PBS.

2. Surgery

  1. Put the animal into an induction chamber and induce anesthesia with 3% isoflurane in oxygen delivered via a calibrated isoflurane vaporizer. Observe the mouse until breathing becomes deep and slow and a toe pinch reflex is absent, about 3-5 min.
  2. Transfer the animal to a stereotaxic frame. Secure the animal's head by putting its mouth on a palate bar with a gas anesthesia mask and by positioning non-perforating ear bars in both ear canals.
  3. Insert a rectal temperature probe and switch on the homeostatic temperature controller.
  4. Apply ophthalmic ointment to prevent eyes from drying out.
  5. Administer preemptive analgesic (e.g., subcutaneous injection of 5 mg/kg carprofen).
  6. Adjust isoflurane to 1-2.5%, according to the depth of the anesthetized state. Monitor temperature, breathing and color of mucous membranes at least every 15 minutes during the procedure.
  7. Shave scalp with electric clippers. Aseptically prepare scalp with three alternating swabs of povidone-iodine and 70% ethanol.
  8. Make an incision in the scalp along the midline starting between the ears and continuing rostral to the eyes, exposing the lambda and bregma sutures. Push skin to the side and remove periosteum from exposed bone if necessary.
  9. Mark the lambda suture with a sterile surgical marker, position the tip of the nanoinjector so that it is just touching lambda, and zero the micromanipulator coordinates. Use the nanoinjector tip and micromanipulator to measure the difference in elevation between the lambda and bregma sutures. Adjust palate bar height to bring lambda and bregma to within ± 100 µm height difference.
  10. Map the injection site using the nanoinjector tip and micromanipulator coordinate system and mark the site with a sterile surgical marker. To inject the IC or DCN of P21-P30 mice, use coordinates relative to the lambda suture, as shown in Table 1. Note that the Z depth in our coordinates is measured from the surface of the skull at lambda.
  11. Use a micromotor drill with a sterile 0.5 mm drill burr to perform a craniotomy over the injection site.
  12. To ensure broad transfection of neurons in the target nucleus, make injections at various depths into the tissue (Table 1, Z coordinates), and, in the case of larger brain regions like the IC, make injections over the course of two or more penetrations at different X and Y coordinates (Table 1, Right IC penetration 1 and Right IC penetration 2).
  13. Perform injections. For IC injections, deposit 20 nL of virus in intervals of 250 µm along the Z axis (injection depth) between 2,250 µm and 1750 µm depth. For DCN injections, deposit 20 nL of virus at a depth of 4,750 µm and 4,550 µm, respectively.
  14. After injection at each Z coordinate, wait 2-3 min before moving the injector to the next Z coordinate. This will allow time for the virus to diffuse away from the injection site, reducing the probability that virus will be sucked up the injection tract when the nanoinjector is repositioned.
  15. After last injection in a penetration, wait 3-5 min before retracting nanoinjector from brain.
  16. When the nanoinjector is removed from the brain between penetrations and between animals, eject a small volume of virus from the tip to check that the tip has not clogged.
  17. After injections, use sterile PBS to wet the cut edges of the scalp and then gently move the skin back towards the midline. Close the wound with simple interrupted sutures using 6-0 (0.7 metric) nylon sutures.
  18. Apply 0.5-1 mL of 2% lidocaine gel to the wound.
  19. Remove ear bars and temperature probe, turn off isoflurane, remove the mouse from the palate bar and transfer it to the recovery cage.
  20. Monitor recovery closely. Once the animal is fully awake, moving around, and showing no signs of pain or distress, transfer it back into its cage and return the cage to the vivarium.
  21. If surgeries will be performed on multiple animals in one day, use a hot bead sterilizer to sanitize surgery tools and drill burr before next surgery.

3. Surgical Follow Up

  1. Check animals daily for wound closure, infection, or signs of pain or distress over the next 10 days, adhering to the institution's animal care guidelines.
  2. Wait 3-4 weeks before using animals in experiments to allow optimal expression of the channelrhodopsins.

4. Brain Slice Preparation and Confirmation of Injection Target

  1. For CRACM, use acutely prepared brain slices from transfected animals in standard in vitro electrophysiology experiments, described here only briefly (see Goyer et al. 2019 for a more detailed description27).
  2. Prepare artificial cerebrospinal fluid (ACSF) containing (in mM): 125 NaCl, 12.5 D-glucose, 25 NaHCO3, 3 KCl, 1.25 NaH2PO4, 1.5 CaCl2, 1 MgSO4. Bubble ACSF to a pH of 7.4 with 5% CO2 in 95% O2.
  3. Perform all following steps, including in vitro electrophysiology, in near-darkness or red light to limit activation of channelrhodopsins.
  4. Deeply anesthetize mouse with isoflurane and decapitate it quickly. Dissect the brain quickly in ~34 °C ACSF.
  5. Cut coronal slices (200-250 µm) containing the IC in ~34 °C ACSF with a vibrating microtome and incubate the slices at 34 °C for 30 min in a holding chamber filled with ACSF bubbled with 5% CO2 in 95% O2. After incubation, store slices at room temperature until used for recordings.
  6. If the injection target was not the IC, cut additional coronal slices of the injected brain region and check the transfection of the target nucleus under a fluorescence microscope. If there is no transfection in the target nucleus or additional transfection in different brain regions, do not continue with experiment.

5. In Vitro Recording and CRACM Experiment

NOTE: To provide optical stimulation of Chronos and ChrimsonR, we use LEDs coupled to the epifluorescence port of the microscope. However, lasers can be used instead of LEDs. If using lasers, obtain prior approval from institutional safety officials and follow appropriate guidelines for safe laser use.

  1. Pull electrodes from borosilicate glass to a resistance of 3.5-4.5 MΩ. The electrode internal solution should contain (in mM): 115 K-gluconate, 7.73 KCl, 0.5 EGTA, 10 HEPES, 10 Na2 phosphocreatine, 4 MgATP, 0.3 NaGTP, supplemented with 0.1% biocytin (w/v), pH adjusted to 7.3 with KOH and osmolality to 290 mOsm/kg with sucrose.
  2. To make recordings, use standard patch clamp methods. Place the slice in a recording chamber under a fixed stage upright microscope and continuously perfuse with ACSF at ~2 mL/min. Conduct recordings near physiological temperature (~34-36 °C).
  3. Patch neurons under visual control using a suitable patch clamp amplifier. Correct for series resistance, pipette capacitance and liquid junction potential.
  4. During whole cell recordings, activate Chronos by delivering brief pulses (1-5 ms) of 470 nm light or ChrimsonR by brief pulses of 580 nm light through commercially available LEDs. Determine threshold of opsin activation and use a minimal stimulation protocol to elicit postsynaptic potentials. In general, use the shortest stimulus duration that elicits a PSP, and set the optical power to 120% of the threshold power required to elicit PSPs.
  5. To confirm that the recorded changes in membrane potential are indeed synaptic inputs to the neuron, standard antagonists for excitatory/inhibitory postsynaptic receptors can be washed in during the experiment. To investigate different receptor contributions to a PSP (e.g. NMDA vs AMPA receptors), suitable receptor antagonists can be washed in. For each receptor antagonist, drug effects should reverse after washout.
  6. Use the latency, jitter, and reliability of PSPs to confirm that light-activated synaptic inputs originate from direct, optical activation of synapses on the recorded neuron, as opposed to activation of channelrhodopsin-expressing synapses on an intervening neuron that synapses on the recorded neuron. In general, low latency (<2 ms), low jitter (<1 ms standard deviation in latency), and high reliability (>50%) indicate a direct synaptic connection from the channelrhodopsin expressing presynaptic neuron to the recorded neuron.

Results

We crossed VIP-IRES-Cre mice (Viptm1(cre)Zjh/J) and Ai14 Cre-reporter mice (B6.Cg-Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/J) to generate F1 offspring in which VIP neurons express the fluorescent protein tdTomato. F1 offspring of either sex were used, aged postnatal day (P) 21 to P70. A total of 22 animals were used in this study.

Stereotaxic injection of AAV1.Syn.Chronos-GFP.WPRE.bGH into the r...

Discussion

We have found that CRACM is a powerful technique for identifying and characterizing long range synaptic inputs to neurons in the mouse IC. Following the protocol detailed here, we achieved robust transfection of neurons in the DCN and IC as well as reliable axonal trafficking of Chronos and ChrimsonR to synaptic terminals in the IC. Additionally, we demonstrated that this technique enables the measurement and analysis of postsynaptic events, including PSP amplitude, halfwidth, decay time, and receptor pharmacology. Our e...

Disclosures

The authors have nothing to disclose.

Acknowledgements

This work was supported by a Deutsche Forschungsgemeinschaft Research Fellowship (GO 3060/1-1, project number 401540516, to DG) and National Institutes of Health grant R56 DC016880 (MTR).

Materials

NameCompanyCatalog NumberComments
AAV1.Syn.ChrimsonR-tdTomato.WPRE.bGHAddgene59171-AAV1
AAV1.Syn.Chronos-GFP.WPRE.bGHAddgene59170-AAV1
Ai14 reporter mice (B6.Cg-Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/J)Jackson Laboratorystock #007914
Amber (590nm) LUXEON Rebel LEDLuxeon Star LEDsSP-01-A8
Blue (470nm) LUXEON Rebel LEDLuxeon Star LEDsSP-01-B4
Carproject (carprofen)Henry Schein Animal Health59149
Drummond glas capillariesDrummond Scientific Company3-000-203-G/X
Drummond Nanoject 3Drummond Scientific Company3-300-207
Electrode bevelerSutter InstrumentFG-BV10-D
Ethilon 6-0 (0.8 metric) nylon suturesEthiconlocal pharmacy
Fixed stage microscopeanyn/a
Gas anesthesia head holderDavid Kopf Instruments933-B
General surgery toolsFine Science ToolsN/A
Golden A5 pet clipperOster078005-010-003
Heating padCustom buildN/A
Hooded induction chamber w/ vacuum systemPatterson Scientific78917760
Hot bead sterilizer Steri 250InotechIS-250
Iodine solution 10%MedChoicelocal pharmacy
Isoflurane vaporizerPatterson Scientific07-8703592
Lidocain topical jelly 2%Akornlocal pharmacy
Micro motor drill 1050Henry Schein Animal Health7094351
Micro motor drill bits 0.5 mmFine Science Tools19007-05
Motorized MicromanipulatorSutter InstrumentMP-285/R
Ophthalmic ointment Artificial TearsAkornlocal pharmacy
P-1000 electrode pullerSutter InstrumentP-1000
Patch clamp amplifier incl data acquisition softwareanyn/a
Portable anethesia machinePatterson Scientific07-8914724
Small animal steroetaxic frameDavid Kopf Instruments930-B
Standard chemicalslocal vendorsN/A
standard imaging solutions
Sterile towel drapesDynarex4410
Surgical markerFine Science Tools18000-30
Temperature controllerCustom buildN/A
Vibratomeanyn/a
VIP-IRES-Cre mice (Viptm1(cre)Zjh/J)Jackson Laboratorystock #010908
Water bathanyn/a

References

  1. Petreanu, L., Huber, D., Sobczyk, A., Svoboda, K. Channelrhodopsin-2-assisted circuit mapping of long-range callosal projections. Nature Neuroscience. 10, 663-668 (2007).
  2. Atasoy, D., Aponte, Y., Su, H. H., Sternson, S. M. A FLEX Switch Targets Channelrhodopsin-2 to Multiple Cell Types for Imaging and Long-Range Circuit Mapping. Journal of Neuroscience. 28, 7025-7030 (2008).
  3. Deisseroth, K. Optogenetics. Nature Methods. 8, 26-29 (2011).
  4. Nagel, G., et al. Channelrhodopsin-2, a directly light-gated cation-selective membrane channel. Proceedings of the National Academy of Sciences. 100, 13940-13945 (2003).
  5. Boyden, E. S., Zhang, F., Bamberg, E., Nagel, G., Deisseroth, K. Millisecond-timescale genetically targeted optical control of neural activity. Nature Neuroscience. 8, 1263-1268 (2005).
  6. Klapoetke, N. C., et al. Independent optical excitation of distinct neural populations. Nature Methods. 11, 338-346 (2014).
  7. Flotte, T. R. Gene Therapy Progress and Prospects: Recombinant adeno-associated virus (rAAV) vectors. Gene Therapy. 11, 805-810 (2004).
  8. Aponte-Ubillus, J. J., et al. Molecular design for recombinant adeno-associated virus (rAAV) vector production. Applied Microbiology and Biotechnology. 102, 1045-1054 (2018).
  9. Kim, C. K., et al. Simultaneous fast measurement of circuit dynamics at multiple sites across the mammalian brain. Nature Methods. 13, 325-328 (2016).
  10. Lin, J. Y., Knutsen, P. M., Muller, A., Kleinfeld, D., Tsien, R. Y. ReaChR: a red-shifted variant of channelrhodopsin enables deep transcranial optogenetic excitation. Nature Neuroscience. 16, 1499-1508 (2013).
  11. Mager, T., et al. High frequency neural spiking and auditory signaling by ultrafast red-shifted optogenetics. Nature Communications. 9, (2018).
  12. Oda, K., et al. Crystal structure of the red light-activated channelrhodopsin Chrimson. Nature Communications. 9, (2018).
  13. Hooks, B. M. Dual-Channel Photostimulation for Independent Excitation of Two Populations. Current Protocols in Neuroscience. 85, e52 (2018).
  14. Schild, L. C., Glauser, D. A. Dual Color Neural Activation and Behavior Control with Chrimson and CoChR in Caenorhabditis elegans. Genetics. 200, 1029-1034 (2015).
  15. Rost, B. R., Schneider-Warme, F., Schmitz, D., Hegemann, P. Optogenetic Tools for Subcellular Applications in Neuroscience. Neuron. 96, 572-603 (2017).
  16. Maimon, B. E., Sparks, K., Srinivasan, S., Zorzos, A. N., Herr, H. M. Spectrally distinct channelrhodopsins for two-colour optogenetic peripheral nerve stimulation. Nature Biomedical Engineering. 2, 485 (2018).
  17. Asrican, B., et al. Next-generation transgenic mice for optogenetic analysis of neural circuits. Frontiers in Neural Circuits. 7, (2013).
  18. Oliver, D. L. Dorsal cochlear nucleus projections to the inferior colliculus in the cat: A light and electron microscopic study. Journal of Comparative Neurology. 224, 155-172 (1984).
  19. Oliver, D. L. Projections to the inferior colliculus from the anteroventral cochlear nucleus in the cat: Possible substrates for binaural interaction. Journal of Comparative Neurology. 264, 24-46 (1987).
  20. Glendenning, K. K., Masterton, R. B. Acoustic chiasm: efferent projections of the lateral superior olive. Journal of Neuroscience. 3, 1521-1537 (1983).
  21. Adams, J. C. Ascending projections to the inferior colliculus. Journal of Comparative Neurology. 183, (1979).
  22. Winer, J. A., Larue, D. T., Diehl, J. J., Hefti, B. J. Auditory cortical projections to the cat inferior colliculus. Journal of Comparative Neurology. 400, 147-174 (1998).
  23. Saldaña, E., Merchań, M. A. Intrinsic and commissural connections of the rat inferior colliculus. Journal of Comparative Neurology. 319, 417-437 (1992).
  24. Sivaramakrishnan, S., Sanchez, J. T., Grimsley, C. A. High concentrations of divalent cations isolate monosynaptic inputs from local circuits in the auditory midbrain. Frontiers in Neural Circuits. 7, (2013).
  25. Felix, R. A., Gourévitch, B., Portfors, C. V. Subcortical pathways: Towards a better understanding of auditory disorders. Hearing Research. 362, 48-60 (2018).
  26. Winer, J. A., Schreiner, C., Winer, J. A., Schreiner, C., et al. . The inferior colliculus: with 168 illustrations. , (2005).
  27. Goyer, D., et al. A novel class of inferior colliculus principal neurons labeled in vasoactive intestinal peptide-Cre mice. eLife. 8, e43770 (2019).

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Explore More Articles

ChannelrhodopsinCircuit MappingInferior ColliculusAuditory Brain StemNeural ProjectionsCRACMStereotaxic Coordinate SystemSurgical ProcedureNano injectorCraniotomyAnesthetic ManagementPreemptive AnalgesicTransfectionMicromanipulator

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved